David A. Hollander
Independent DirectorDr. David A. Hollander, M.D., M.B.A., is Chief R&D Officer of Veradermics, Incorporated from October 2026. Dr. Hollander serves as Chief Medical Officer of Okogen, Inc since July 2025. He served as Chief Medical Officer of Global Therapeutics Franchise Lead at Revance Therapeutics Inc. since 2024. He served as Chief Medical Officer at Revance Therapeutics, Inc. since January 2023 until 2024 and served as its Chief medical Officer since October 2022. He served as Chief Research & Development Officer at Aerie Pharmaceuticals, Inc. since November 11, 2019 until February 28, 2022. He serves as an Independent Director at Kiora Pharmaceuticals, Inc. since December 31, 2021. Dr. Hollander directs Aerie's preclinical and clinical research and development groups, as well as medical and professional affairs. He has outstanding credentials and an impressive track record. He was Chief Medical Officer and Senior Vice President at Ora, Inc the leading ophthalmic Contract Research Organization, from April 2016 to November 2019. Dr. Hollander brought outstanding credentials and an impressive track record to Aerie. He began his career on faculty at Jules Stein and served as Assistant Chief of Ophthalmology at the Greater Los Angeles VA Medical Center. Dr. Hollander began his career in industry in 2006 at Allergan as a Medical Director of Ophthalmology He then spent a decade at Allergan where his leadership roles included Head of EyeCare for Global Medical Affairs, as well as Vice President and Therapeutic Area Head of Anterior Segment Clinical Development. During this time, he was able to continue to see patients and teach residents in the operating room and clinic as an ophthalmologist. He is an author on more than 75 peer-reviewed publications, has given more than 100 presentations nationally and internationally and holds multiple patents. He holds a B. S. in Chemistry from Stanford University, an M. D. from the University of Pennsylvania School of Medicine and an M. B.A. from the Wharton School. His post-doctoral training included an internship in internal medicine at Cedars-Sinai Medical Center, a residency in ophthalmology at UCSF and a fellowship in cornea, external-ocular disease and refractive surgery at UCLA's Jules Stein Eye Institute.
Positions
- Company NameKiora Pharmaceuticals, Inc.Stock CodeKPRXPositionIndependent DirectorColleagues
- BMBrian M. StremPresident, CEO & Director
- PTPraveen TyleIndependent Chairman of the Board
- MTMelissa ToscaChief Financial Officer
- SSStefan SperlExecutive Vice President of CMC & Operations
- KJKeith J. LaneExecutive VP and Head of Clinical Development & Regulatory Affairs
- EPErin ParsonsNon-Employee Independent Director
- LWLisa Walters-HoffertIndependent Director
